Aclaris Therapeutics (ACRS) Share-based Compensation Growth (1y) (2015 - 2026)
Aclaris Therapeutics (ACRS) Share-based Compensation Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 71.86% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -3.46% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -8.89% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1,486.54% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -22.43% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -4.01% |
| 10 | Aclaris Therapeutics | 808.18 Mn | 716.63 Mn | 1.41 Mn | 487.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 487.66% |
| Mar 31, 2026 | 7,063.64% |
| Dec 31, 2025 | 745.92% |
| Sep 30, 2025 | -4.79% |
| Jun 30, 2025 | 382.26% |
| Mar 31, 2025 | -86.84% |
| Dec 31, 2024 | 97.65% |
| Sep 30, 2024 | -49.50% |
| Jun 30, 2024 | -55.49% |
| Mar 31, 2024 | -69.31% |
| Dec 31, 2023 | -500.66% |
| Sep 30, 2023 | 42.02% |
| Jun 30, 2023 | 76.65% |
| Mar 31, 2023 | 190.11% |
| Dec 31, 2022 | 24.98% |
| Sep 30, 2022 | 13.13% |
| Jun 30, 2022 | -3.65% |
| Mar 31, 2022 | -38.78% |
| Dec 31, 2021 | 53.79% |
| Sep 30, 2021 | 3,996.84% |